RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
RhoA Drives T-Cell Activation and Encephalitogenic Potential in an Animal Model of Multiple Sclerosis
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2018-05-31
DOI
10.3389/fimmu.2018.01235
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- T-cell activation RhoGTPase-activating protein plays an important role in TH 17-cell differentiation
- (2017) Norimasa Tamehiro et al. IMMUNOLOGY AND CELL BIOLOGY
- Targeting the GM-CSF receptor for the treatment of CNS autoimmunity
- (2017) Igal Ifergan et al. JOURNAL OF AUTOIMMUNITY
- Selection of first-line therapy in multiple sclerosis using risk-benefit decision analysis
- (2017) David Bargiela et al. NEUROLOGY
- Multiple sclerosis: Pathology, diagnosis and treatments
- (2017) Wen-Juan Huang et al. Experimental and Therapeutic Medicine
- Efficacy, safety, and pharmacokinetics of natalizumab in Japanese multiple sclerosis patients: A double-blind, randomized controlled trial and open-label pharmacokinetic study
- (2017) Takahiko Saida et al. Multiple Sclerosis and Related Disorders
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Ingested (oral) anti-IL-12/23 inhibits EAE
- (2016) Staley A. Brod JOURNAL OF THE NEUROLOGICAL SCIENCES
- A basic overview of multiple sclerosis immunopathology
- (2015) N. Grigoriadis et al. EUROPEAN JOURNAL OF NEUROLOGY
- Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential
- (2015) Yangbo Feng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Pathological mechanisms in progressive multiple sclerosis
- (2015) Don H Mahad et al. LANCET NEUROLOGY
- Daclizumab HYP versus Interferon Beta-1a in Relapsing Multiple Sclerosis
- (2015) Ludwig Kappos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting Rho-GTPases in immune cell migration and inflammation
- (2014) Maté Biro et al. BRITISH JOURNAL OF PHARMACOLOGY
- Fasudil mediates cell therapy of EAE by immunomodulating encephalomyelitic T cells and macrophages
- (2014) Chun-Yun Liu et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Gene Targeting RhoA Reveals Its Essential Role in Coordinating Mitochondrial Function and Thymocyte Development
- (2014) Shuangmin Zhang et al. JOURNAL OF IMMUNOLOGY
- Alemtuzumab treatment of multiple sclerosis: long-term safety and efficacy
- (2014) O. Tuohy et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study
- (2014) Peter A Calabresi et al. LANCET NEUROLOGY
- Drugs in Development for Relapsing Multiple Sclerosis
- (2013) Rehiana Ali et al. DRUGS
- 2-photon imaging of phagocyte-mediated T cell activation in the CNS
- (2013) Marija Pesic et al. JOURNAL OF CLINICAL INVESTIGATION
- Involvement of the MAPK and RhoA/ROCK pathways in PGE2-mediated CCR7-dependent monocyte migration
- (2012) Marc-André Allaire et al. IMMUNOLOGY LETTERS
- Alemtuzumab more effective than interferon -1a at 5-year follow-up of CAMMS223 Clinical Trial
- (2012) A. J. Coles et al. NEUROLOGY
- Rho GTPases: Masters of T lymphocyte migration and activation
- (2011) Pablo Rougerie et al. IMMUNOLOGY LETTERS
- RhoA is dispensable for skin development, but crucial for contraction and directed migration of keratinocytes
- (2011) Ben Jackson et al. MOLECULAR BIOLOGY OF THE CELL
- Epidemiology of Multiple Sclerosis
- (2011) Sreeram V. Ramagopalan et al. NEUROLOGIC CLINICS
- T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
- (2010) J. M. Fletcher et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Coordinated RhoA signaling at the leading edge and uropod is required for T cell transendothelial migration
- (2010) Sarah J. Heasman et al. JOURNAL OF CELL BIOLOGY
- Averting inflammation by targeting the cytokine environment
- (2010) Manfred Kopf et al. NATURE REVIEWS DRUG DISCOVERY
- New pieces in the puzzle: How does interferon-β really work in multiple sclerosis?
- (2009) Meike Mitsdoerffer et al. ANNALS OF NEUROLOGY
- Rho Kinase (ROCK) Inhibitors and Their Application to Inflammatory Disorders
- (2009) Philip LoGrasso et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Glatiramer acetate improves regulatory T-cell function by expansion of naive CD4+CD25+FOXP3+CD31+ T-cells in patients with multiple sclerosis
- (2009) Juergen Haas et al. JOURNAL OF NEUROIMMUNOLOGY
- Spatiotemporal Patterning During T Cell Activation Is Highly Diverse
- (2009) K. L. Singleton et al. Science Signaling
- Multiple Sclerosis: An Immune or Neurodegenerative Disorder?
- (2008) Bruce D. Trapp et al. Annual Review of Neuroscience
- Multiple sclerosis
- (2008) Alastair Compston et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation